![]() Paion PAION is a biopharmaceutical company developing and commercializing drug candidates for diseases with substantial unmet medical needs. | ![]() Array BioPharma Array BioPharma is focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. | ![]() ObsEva ObsEva is a speciality biopharmaceutical company developing drugs for womens reproductive medicine. | |
Founding Date | Founding Date 2000 | Founding Date 1998 | Founding Date 2012 |
Type | Type Public | Type Subsidiary | Type Private |
Tags | |||
Locations | Locations Aachen, DE HQ Odense, DK Hoofddorp, NL Richmond, GB | Locations Boulder, US HQ Chicago, US Detroit, US Houston, US Miami, US New York, US Phoenix, US | Locations Plan-les-Ouates, CH HQ Boston, US Sacramento, US |
Employees | Employees 3218% decrease | Employees 110 | Employees 811% decrease |
Financial | |||
Revenue (est.) | Revenue (est.) €33.2m (FY, 2022) | Revenue (est.) $173.8m (FY, 2018) | Revenue (est.) N/A |
Cost of goods | Cost of goods €382k (FY, 2022) | Cost of goods $59.4m (FY, 2018) | Cost of goods N/A |
Gross profit | Gross profit €33.4m (FY, 2022) | Gross profit $114.4m (FY, 2018) | Gross profit N/A |
Net income | Net income (€579k) (FY, 2022) | Net income ($147.7m) (FY, 2018) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised $ 15.2m | Total funding raised N/A | Total funding raised $ 92.9m |

Array BioPharma is focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.
View company
ObsEva is a speciality biopharmaceutical company developing drugs for womens reproductive medicine.
View company